MapLight Therapeutics, Inc. (MPLT)

NASDAQ: MPLT · Real-Time Price · USD

21.17

+0.34 (1.63%)

At close: Apr 2, 2026, 4:00 PM EDT

21.17

0.00 (0.00%)

After-hours: Apr 2, 2026, 4:10 PM EDT

MapLight Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Selling, General & Admin	30.73	14.42	7.61	4.1
Research & Development	138.35	68.52	49.68	27.14
Operating Expenses	169.08	82.95	57.28	31.25
Operating Income	-169.08	-82.95	-57.28	-31.25
Interest & Investment Income	5.52	4.5	1.1	0.43
Earnings From Equity Investments	-	-0.99	0.99	-
Currency Exchange Gain (Loss)	-	-	-	0
Other Non Operating Income (Expenses)	0.31	0.11	-0.51	0.8
EBT Excluding Unusual Items	-163.25	-79.32	-55.71	-30.02
Gain (Loss) on Sale of Investments	2.1	1.74	-	-
Pretax Income	-161.15	-77.58	-55.71	-30.02
Net Income	-161.15	-77.58	-55.71	-30.02
Net Income to Common	-161.15	-77.58	-55.71	-30.02
Shares Outstanding (Basic)	9	1	1	1
Shares Outstanding (Diluted)	9	1	1	1
Shares Change (YoY)	1079.16%	11.60%	18.43%	-
EPS (Basic)	-18.56	-105.38	-84.45	-53.89
EPS (Diluted)	-18.56	-105.38	-84.45	-53.89
Free Cash Flow	-138.61	-79.59	-52.47	-27.32
Free Cash Flow Per Share	-15.97	-108.11	-79.54	-49.05
EBITDA	-168.51	-82.25	-56.73	-30.67
D&A For EBITDA	0.58	0.7	0.56	0.57
EBIT	-169.08	-82.95	-57.28	-31.25

Updated Mar 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q